RECOMBINANT HANSENULA-BASED HIGH DOSAGE HEPATITIS B VACCINE
- 专利权人:
- WANG; Hemu
- 发明人:
- WANG, Changhua,WANG, Hemu,YANG, Jun
- 申请号：
- SG11201808268U
- 公开号：
- SG11201808268UA
- 申请日:
- 2017.03.16
- 申请国别(地区):
- SG
- 年份:
- 2018
- 代理人:
- 摘要：
- Provided is a recombinant Hansenula-based high dosage hepatitis B vaccine, an HBsAg pure stock solution yield of a recombinant Hansenula fermentation broth used for producing the hepatitis B vaccine being 300mg/L- 400mg/L.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- HEPATITIS HEPATITIS B VACCINE BASED ON HANSENULA POLYMORPHA RECOMBINANT
- HEPATITIS B TREATMENT VACCINE BASED ON INACTIVATED WHOLE RECOMBINANT HANSENULA CELL WHICH EXPRESSES HBSAG AND HBCAG
- HEPATITIS B TREATMENT VACCINE ON THE BASIS OF INACTIVATED, FULLY RECOMBINANT HANSENULA CELLS EXPRESSING HBSAG
- HEPATITIS B TREATMENT VACCINE ON THE BASIS OF INACTIVATED, WHOLE RECOMBINANT HANSENULA POLYMORPHA CELLS EXPRESSING HBSAG
- Combined vaccines comprising Hepatitis B surface and other antigens
